Fig. 2From: A novel strain of Bacillus amyloliquefaciens displaying broad spectrum antifungal activity and its underlying mechanismMorphology of control and purified antifungal secondary metabolite-treated Aspergillus parasiticus NRRL 3145 hyphae under light microscope. a Control mycelium, not treated with metabolite (magnification 40 × 10), s test mycelium after being treated with the purified lipopeptide (2 μg/ml) for 24 h (magnification 40 × 10)Back to article page